Confidence From the Start

The first and only closed-loop SCS system powered by objective neural data to deliver predictable, durable pain relief from day one.

Get in Touch

Meet the Evoke® System

Disrupting pain by removing guesswork.

Listens to the spinal cord
The dose is anchored to each patient’s individual physiology – unlike others that are set subjectively by the programmer.
Therapy is individually calibrated from the start
Measures and confirms the spinal cord’s response to stimulation for each unique patient, starting on day one of the trial phase.
Automatically adjusts to maintain consistent pain relief
Continual adjustments address both over AND under dosing for sustainable, predictable pain relief.

Objective by Design

The Evoke® System Powered by SmartLoop^TMTechnology

SmartLoop^TM technology enables clinicians to directly measure and prescribe an optimised dose of stimulation. It then auto-adjusts on every pulse, over 4+ million times a day*, to deliver consistent pain relief with every heartbeat, breath, and movement. .

Redefining Spinal Cord Stimulation

That WasThen

Fixed-Output SCS:

Unknown and inconsistent
dosing

Cannot auto-adjust for movement and
physiological changes throughout the day

This IsNow

Known and consistent
dosing

Automatically adjusts in real time to maintain consistent activation across activities

Learn More

Know the Whole Story

Introducing the Evoke™ Therapy Report

Subjective feedback tells half the story. Only the Evoke™ Therapy report provides physiological insights along with patient reported outcomes, empowering clinicians to make more informed clinical decisions.

PROVEN EVIDENCE

Proven in Practice

Backed by the landmark EVOKE Study—The only SCS therapy with double-blinded RCT evidence with 36-month outcomes.¹

0 %

of patients are pain responders (≥50% VAS reduction)

0 %

of patients are high-pain responders (≥80% VAS reduction)

0 %

of three month responders were still responders at three years

closed-loop explants due to loss of efficacy

Disrupting the SCS Market

The Evoke® System is redefining what’s possible in spinal cord stimulation.

	Evoke® System with Smartloop™ Technology	Other Closed-Loop SCS Therapies	Fixed-Output SCS Therapies
Clinical Superiority Proven Out to 36-Months	✓¹	X	X
Senses ECAPs	✓	✓	X
Sets Target ECAP Dose	✓	X² Uses ECAPs to React to Overstimulation	X
Percent of Time Actively Adjusting	100%	<10%³	X
Controls for Overdosing	✓	X ~46% of Patients Still Experience Overstimulation⁴	X
Controls for Underdosing	✓	X⁴	X
Ability to Sense and Respond in the Trial Evaluation	✓	X	X
Ability to Drive with Closed-Loop Therapy	✓	X⁵	X
Full-Body MRI Conditional Labeling	✓⁶	✓⁷	✓

Have questions?

Connect with us to learn how the Evoke® System can become a valuable part of your practice.